万维提示：
1、投稿方式：在线投稿。
2、期刊网址：http://www.biotechnology-journal.com/
https://onlinelibrary.wiley.com/journal/18607314
3、投稿网址：http://mc.manuscriptcentral.com/btj
4、官网邮箱：
biotechnology-journal@wiley.com（编辑部）
aliu@wiley.com；btj@wiley.com（编辑部）
5、期刊刊期：月刊，一年出版12期。
2022年1月4日星期二
投稿须知【官网信息】
Biotechnology Journal Instructions to Authors
Manuscript submission:
http://mc.manuscriptcentral.com/btj
Contact the Editorial Office at: btj@wiley.com
As of January 2014, Biotechnology Journal is available as a fully online publication in response to environmental concerns and changes in user requirements. We will continue to publish the latest breakthrough research in biotechnology while reducing our environmental footprint. Authors have the added benefit that there are no color charges or any other charges associated with publishing in Biotechnology Journal (with the exception of those authors who opt-in to OnlineOpen, for which a fee is levied to make the article freely accessible to all).
Authors are requested to follow these Instructions carefully. Manuscripts missing all necessary information requested for peer review will be returned to authors – this inevitably leads to a delay in the editorial processing of the manuscript. Please refer to our Appendix B for Authors for a quick checklist.
1. ABOUT BIOTECHNOLOGY JOURNAL
Biotechnology Journal (BTJ) is an international resource for both biotechnology researchers and professionals in related disciplines. Fully comprehensive in its scope, the Journal publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Special attention is also paid to the public, legal, ethical and cultural aspects of biotechnological research in the Forum section. Some issues are devoted to a special topic, providing the latest comprehensive information on the most crucial areas of research and technological advances. In addition to special issues, the journal welcomes unsolicited submissions both for primary research articles and for reviews. Biotechnology Journal is edited by Sang Yup Lee and Alois Jungbauer.
1.1. AIMS AND SCOPE
The Journal contains original papers in the form of Research Articles, Rapid Communications and Biotech Methods, illustrating the latest research results. BTJ welcomes submission of papers in areas including DNA/protein engineering, all –omics fields (genomics, proteomics, metabolomics, systems biology etc.), bioinformatics (algorithms and modeling), imaging, analytical biotech (sensors/detectors for analytes/macromolecules), plant/agricultural, food or environmental biotechnology, medical biotechnology (including antisense/siRNAs, enzymes, peptide, etc.), regenerative medicine (stem cells, tissue engineering and biomaterials), translational immunology (antibody engineering, xenotransplantation, cellular therapies), and biosafety or biosecurity.
BTJ promotes a special emphasis on:
Systems Biotechnology
High-Throughput and Microarray Technologies
Synthetic Biology and Metabolic Engineering
Nanobiotechnology
Medical Biotechnology
Translational Biotechnology and Applied Microbiology
Methods and Advances
Biosafety, Biotech Ethics, Science Communication
In particular, BTJ welcomes submissions on: Systems Biology/Bioinformatics: Overview and interplay between biological system components and their functional implications (e.g. enzymes and metabolites in a metabolic pathway). Computational analysis of all topics mentioned below (modeling, algorithms, data deconvolution).
Synthetic Biology: The design and construction of new biological parts, devices and systems; re-design of natural biological systems for useful purposes.
Nanobiotech/ Biomaterials: Nanomaterials for industrial (white) biotech, drug delivery therapeutics, biochips, micro- and nanofluidics, nanosensors, and nanosystems for imaging; engineering materials for biological application, molecular imprinting, and biomimetics.
Medicine/ Red Biotech/ Stem cells: Therapeutic cloning (somatic cell nuclear transfer), tissue engineering, xenotransplantation; DNA or RNA therapeutics (gene therapy, targeting, immunogenicity); vaccines and applied immunology (Ab engineering, T-cell therapies, therapies exploiting innate immunity, antigen delivery vectors and approaches; viral or nonviral strategies for drug delivery.
……
更多详情：
https://onlinelibrary.wiley.com/pb-assets/assets/18607314/BTJ_Instructions_to_authors_2018-1519640119293.pdf
